Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India

NCT00923702 is registered in ClinicalTrials.gov with Partha Basu as lead sponsor.

NCT NCT00923702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00923702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India
Lead sponsor
Partha Basu
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2009
Completion date
July 31, 2026
Enrollment
22,729 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, cervical precancerous lesions